(E)-N-(4-((3-Bromo-4-chlorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)-4-(dimethylamino)but-2-enamide

Catalog No. :
ACVMRS938
CAS No. :
2135696-72-7
Molecular Formula :
C19H18BrClN6O
Molecular Weight :
461.75

IUPAC Name:(E)-N-(4-((3-bromo-4-chlorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)-4-(dimethylamino)but-2-enamide

(E)-N-(4-((3-Bromo-4-chlorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)-4-(dimethylamino)but-2-enamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$241.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-N-(4-((3-Bromo-4-chlorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)-4-(dimethylamino)but-2-enamide
IUPAC Name(E)-N-(4-((3-bromo-4-chlorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)-4-(dimethylamino)but-2-enamide
Molecular FormulaC19H18BrClN6O
Molecular Weight461.75
SMILESBrC1=C(Cl)C=CC(NC2=NC=NC3=C2C=C(NC(/C=C/CN(C)C)=O)N=C3)=C1
InChI KeyQBACGOWRJDBXSG-ONEGZZNKSA-N
SynonymSCHEMBL11903013 | EX-A3689 | GTPL9410 | Kinase inhibitor-1 | (2E)-N-{4-[(3-bromo-4-chlorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl}-4-(dimethylamino)but-2-enamide | QBACGOWRJDBXSG-ONEGZZNKSA-N | Tarlox-TKI | RN4000E | RN-4000E | SCHEMBL11903016 | MJ8D2M76W
CAS No.2135696-72-7
PubChem CID51037658

Synthetic Route by SureRoute

1. ACVMRS938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMRS938 route product structure diagram
    ACVMRS9382135696-72-7
Inquiry

2. ACVMRS938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMRS938 route product structure diagram
    ACVMRS9382135696-72-7
Inquiry

Comments (0)